Literature DB >> 24717882

Influenza vaccinations and chemosensory function.

Richard L Doty1, Austin H Berman, Mohammad Izhar, Hugh B Hamilton, Danylko Villano, Britney E Vazquez, Maja N Warrum, Mariam Mahbob.   

Abstract

BACKGROUND: Although influenza vaccines have saved millions of lives, some have been associated with extremely rare adverse effects such as Guillain-Barré syndrome, Bell's palsy, and optic neuritis. Despite the fact that olfactory loss after an influenza vaccination is noted in one case report, no quantitative olfactory testing was performed. Hence, it is unclear whether, in fact, olfactory dysfunction can be associated with such vaccinations. This study was designed to (1) identify patients from the University of Pennsylvania Smell and Taste Center who attributed their empirically determined chemosensory disturbances to influenza vaccinations and (2) determine whether influenza vaccinations add to the degree of olfactory or gustatory dysfunction due to other causes.
METHODS: A retrospective analysis of self-reported etiologies of 4554 consecutive patients presenting to the University of Pennsylvania Smell and Taste Center with complaints of chemosensory dysfunction was performed. Those who reported dysfunction secondary to influenza vaccinations were identified. Additionally, in a subset of 925 patients for whom detailed inoculation histories were available, it was determined whether the number of lifetime inoculations added to the deficits due to other causes.
RESULTS: Nine of the 4554 patients (0.19%) attributed olfactory disturbances to an influenza vaccination. None complained of taste dysfunction. All nine had abnormally low scores on the University of Pennsylvania Smell Identification Test (p < 0.001), with three being anosmic and six microsmic. Seven had elevated phenyl ethyl alcohol detection thresholds (p < 0.05). Two cases exhibited mild-to-moderate loss of whole mouth taste function. Of the 925 patients, no association was evident between the number of lifetime vaccinations and the chemosensory test scores. In accord with previous studies, age and sex were significantly related to the test scores.
CONCLUSION: A very small percentage of the 4554 patients evaluated (0.19%) attributed their chemosensory dysfunction to a prior influenza vaccination. No influences of the number of lifetime influenza vaccinations on the test scores were evident in the subset of 925 patients whose dysfunction was due to other causes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24717882     DOI: 10.2500/ajra.2014.28.3987

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  5 in total

1.  Editorial: Insight into allergic, rhinologic and skull based pathologies.

Authors:  Jean Anderson Eloy
Journal:  Am J Rhinol Allergy       Date:  2014 Jan-Feb       Impact factor: 2.467

2.  Drug-Associated Parosmia: New Perspectives from the WHO Safety Database.

Authors:  Diane Merino; Alexandre Olivier Gérard; Susanne Thümmler; Nouha Ben Othman; Delphine Viard; Fanny Rocher; Alexandre Destere; Elise Katheryne Van Obberghen; Milou-Daniel Drici
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

3.  Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective.

Authors:  Marta Mazur; Irena Duś-Ilnicka; Maciej Jedliński; Artnora Ndokaj; Joanna Janiszewska-Olszowska; Roman Ardan; Malgorzata Radwan-Oczko; Fabrizio Guerra; Valeria Luzzi; Iole Vozza; Roberto Marasca; Livia Ottolenghi; Antonella Polimeni
Journal:  Int J Environ Res Public Health       Date:  2021-05-07       Impact factor: 3.390

Review 4.  The Crossroads between Host Copper Metabolism and Influenza Infection.

Authors:  Ludmila V Puchkova; Irina V Kiseleva; Elena V Polishchuk; Massimo Broggini; Ekaterina Yu Ilyechova
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

5.  Anti-Influenza Effect of Nanosilver in a Mouse Model.

Authors:  Irina V Kiseleva; Mohammad Al Farroukh; Ekaterina A Skomorokhova; Andrei R Rekstin; Ekaterina A Bazhenova; Daria N Magazenkova; Iurii A Orlov; Larisa G Rudenko; Massimo Broggini; Ludmila V Puchkova
Journal:  Vaccines (Basel)       Date:  2020-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.